✦ LIBER ✦

Retreatment of chronic hepatitis C patients with previous non response to interferon alone

✍ Scribed by Carmen Vandelli; Francesco Renzo; Chiara Vecchi; Maria Luisa Zeneroli; Monica Pecorari; Sergio Tisminetzky

Book ID: 118565397
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 112 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80481-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment of chronic hepatitis C patie

Retreatment of chronic hepatitis C patients with previous non-response to interferon alone

✍ C. Vandelli; F. Renzo; C. Vecchi; E. Ventura; S. Tisminetzky 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Retreatment of chronic hepatitis C patie

Retreatment of chronic hepatitis C patients with interferonplusribavirin vs interferon alone

✍ C. Vandelli; F. Renzo; C. Vecchi; E. Lovato; S. Tisminetzky; E. Ventura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Interferon retreatment in patients with

Interferon retreatment in patients with chronic hepatitis C

✍ C. Vandelli; F. Renzo; F. Baralle; E. Lovato; S. Tisminetzky; E. Ventura 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Retreatment with interferon in patients

Retreatment with interferon in patients with chronic hepatitis C

✍ Shinichi Kakumu; Kentaro Yoshioka 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Retreatment of interferon relapse patien

Retreatment of interferon relapse patients with chronic hepatitis C

✍ Maria Buti; Rafael Esteban 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of